BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 7188815)

  • 1. Multiple daily amphetamine administration: behavioral and neurochemical alterations.
    Segal DS; Weinberger SB; Cahill J; McCunney SJ
    Science; 1980 Feb; 207(4433):905-7. PubMed ID: 7188815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple daily amphetamine administration: behavioral and neurochemical alterations.
    Segal DS; Weinberger SB; Cahill J; McCunney SJ
    Science; 1980 Feb; 207(4433):904-7. PubMed ID: 17729873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral depression and its neurochemical correlates at high doses of d-amphetamine in rats.
    Copeland RL; Aulakh CS; Bhattacharyya AK; Pradhan SN
    Neuropharmacology; 1980 Oct; 19(10):1027-30. PubMed ID: 7191484
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study of d- and l-amphetamine on the open field performance of rats.
    Dandiya PC; Kulkarni SK
    Psychopharmacologia; 1974; 39(1):67-70. PubMed ID: 4472934
    [No Abstract]   [Full Text] [Related]  

  • 5. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics.
    Segal DS; Kuczenski R
    J Neurosci; 1997 Apr; 17(7):2551-66. PubMed ID: 9065515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced locomotor activity following amphetamine in mouse-killing rats.
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):162-9. PubMed ID: 4795753
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic and experimental factors in the behavioral response to repeated amphetamine.
    Browne RG; Segal DS
    Pharmacol Biochem Behav; 1977 May; 6(5):545-52. PubMed ID: 561406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy.
    Segal DS; Mandell AJ
    Pharmacol Biochem Behav; 1974; 2(2):249-55. PubMed ID: 4857295
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced responsiveness to intraventricular infusion of amphetamine following its repeated systemic administration.
    Rebec GV; Segal DS
    Psychopharmacology (Berl); 1979 Mar; 62(1):101-2. PubMed ID: 108743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates.
    Segal DS; Kuczenski R
    J Pharmacol Exp Ther; 1987 Sep; 242(3):917-26. PubMed ID: 3656119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L; Irwin J; Anisman H
    Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential effects of para-chlorophenylalanine on amphetamine-induced locomotion and stereotypy.
    Segal DS
    Brain Res; 1976 Nov; 116(2):267-76. PubMed ID: 135600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.
    Creese I; Iversen SD
    Brain Res; 1973 Jun; 55(2):369-82. PubMed ID: 4145950
    [No Abstract]   [Full Text] [Related]  

  • 14. Cats develop tolerance to d-amphetamine's effects upon locomotion and stereotyped behaviors.
    Jacobs BL; Heym J; Trulson ME
    Eur J Pharmacol; 1981 Jan; 69(3):353-6. PubMed ID: 7194184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion.
    Robinson TE; Camp DM
    Pharmacol Biochem Behav; 1987 Apr; 26(4):821-7. PubMed ID: 2440058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization.
    Segal DS; Kuczenski R
    J Pharmacol Exp Ther; 1997 Aug; 282(2):561-73. PubMed ID: 9262316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential behavioral responses of spontaneously hypertensive (SHR) and normotensive (WKY) rats to d-amphetamine.
    McCarty R; Chiueh CC; Kopin IJ
    Pharmacol Biochem Behav; 1980 Jan; 12(1):53-9. PubMed ID: 6445066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of phencyclidine on amphetamine stereotypy in rats.
    Balster RL; Chait LD
    Eur J Pharmacol; 1978 Apr; 48(4):445-50. PubMed ID: 565717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two dissociable components of behavioral sensitization following repeated amphetamine administration.
    Leith NJ; Kuczenski R
    Psychopharmacology (Berl); 1982; 76(4):310-5. PubMed ID: 6812103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.